MET and neoplasm: In addition, glioma expressing PTPRZ1-MET (ZM) gene fusions show potent invasiveness and sensitivity to chemotherapy drugs (International Cancer Genome Consortium PedBrain Tumor Project, 2016; Hu H. et al., 2018).